| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.41 | 0.02 |